tirzepatide phase 3 Lilly orforglipron oral GLP-1 weight loss trial tirzepatide maximum weight loss surmount

The goal was studies focused on GLP-1 in GDM treatment

A microwave power of 6.3 mW and a modulation amplitude of 5 G at a modulation frequency of 100 kHz were used to acquire spectra in the range of 3367 G to 3497 G at a sweep time of 156.22 s and a conversion time of 78.11 ms

In many cases, dizziness is not caused by tirzepatide alone

Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI

Pharmacokinetic studies have shown reduced exposure to ethinyl estradiol and progestins after tirzepatide initiation, with the greatest effect occurring after initial doses and dose escalations